L. Moutouh-de Parseval

发表

Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.

Dirk Schadendorf, Reinhard Dummer, Naoya Yamazaki, 2018, The Lancet. Oncology.

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.

D. Schadendorf, K. Flaherty, P. Ascierto, 2018, The Lancet. Oncology.

Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.

K. Nakayama, K. Nakayama, D. Kuhn, 2008, Blood.

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma

R. Sullivan, M. Hidalgo, G. Caponigro, 2017, Clinical Cancer Research.

Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.

J. Corbeil, D. Richman, S. Little, 2003, The Journal of infectious diseases.

Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells.

D. Verhelle, P. Schafer, K. Jensen-Pergakes, 2007, Cancer research.

Effects of Antiretroviral Drugs on Human Immunodeficiency Virus Type 1-Induced CD4+ T-Cell Death

J. Corbeil, D. Richman, T. Brunner, 2002, Journal of Virology.

Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.

J. Zeldis, R. Knight, L. Weiss, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Transient MEK inhibitor-associated retinopathy in metastatic melanoma.

M. Urner, R. Dummer, A. Zubel, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia

E. Kimby, J. Gribben, F. Bosch, 2012, Leukemia & lymphoma.

Transient MEK inhibitor-associated retinopathy in metastatic melanoma.

M. Urner, R. Dummer, A. Zubel, 2014 .

Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice.

P. Swerdlow, A. Kutlar, L. Corral, 2011, Blood.

Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells.

D. Verhelle, K. Jensen-Pergakes, L. Corral, 2008, Journal of Clinical Investigation.

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

J. Briones, I. Flinn, D. Blaise, 2023, Cancer discovery.

Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.

K. Nakayama, K. Nakayama, D. Kuhn, 2008, Blood.